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Computer modeling is an important tool of contemporary scientific research. It allows 
to study the structure, conformation, dynamics and mutual interaction of nonbinding 
interactions of a biological system. The main objective is to find the best energy conformations 
by minimizing the energy of the system. On the base of these calculated values, one can predict 
the loss of activity for certain analogous compounds, thus reducing the number of materials 
that would be needed to subsequently synthesize. A molecular modeling contributes to describe 
the  interactions of ligands with larger systems and improves the orientation in millions of active 
substances that could be used as potential drug. It becomes an important part 
of the pharmaceutical industry. 
The aim of this study was to verify the selected methodology of computer prediction 
of protein-ligand complexes, to obtain a description of the basic interactions of the modulators 
of cholinesterase enzymes by molecular modeling, and on the basis of this knowledge to design 
the structure of a new potent inhibitor of acetylcholinesterase. For the in silico testing, 
the  modulators synthesized in the present thesis and in the previous diploma thesis, compounds 
prepared by students in collaboration with the Department of Pharmaceutical Chemistry 
Pharmaceutical and Pharmaceutical analysis, Faculty of Charles University and the Department 
of Toxicology, Faculty of Military Health Sciences, University of Defence, and also widely 
used acetylcholinesterase modulators were used.  
The method validation was performed at several crystal structures. The obtained results 
were used to describe the relationships between the basic structure and a manner of interaction 
and the affinity for the enzyme. According to endpoints some several potential inhibitors 
of acetylcholinesterase were obtained. Their interaction with the enzyme was described 
and their physical characteristics were calculated, too. These substances can be used 
in the prophylaxis of nerve agent poisoning or treating Alzheimer's disease or myasthenia 
gravis. The results were published in scientific journals and presented as posters at scientific 
conferences in Czech Republic and abroad. 
